A Scorpion’s Poison Antivenin R&D+i Project Case from a Mexican Public University – Conclusions

A Scorpion’s Poison Antivenin R&D+i Project Case from a Mexican Public University - ConclusionsAs proposed by Geisler, and Choi,, following are some project remarkable successful aspects along its lifecycle:
Stage 1 Basic Research: extraordinary research team and leadership, developing new scientific knowledge, with high annual international indexed publications and high quality human resources formation.
Stage 2. Applied research & technological development: they developed integrated laboratory prototypes for the antivenin technologies and patented them.
Stage 3. Technology transfer and product development: the group pursued a technology transfer and licensing agreement with annual royalties’ payment for the UNAM; they also developed a pilot plant for the initial serum production.
Stage 4. Market launch & technology diffusion: the licensed firm developed a local market of more than 5000 antivenin units per year and overseas market of more than $100 USD million by 2007. The expectation is to double this for 2013.
Stage 5. High Economic impacts: The expectation is to double the 2007 sales for 2013; high social impacts, saving several hundreds of thousands of injured people all around the world.
According to Vandervert, innovation has to be with the production of new ideas and useful products, including of course pharmaceutical products. Presented case have had great social impact saving the life of hundreds of people in Mexico, north Africa, Middle East and USA while at the same time the firm which produces and sells the products is obtaining good profit in all the markets developed.
Furthermore, in projects like this everybody wins, beginning with starters, people that unfortunately receive a scorpion sting but is properly treated with the antivenin and reacts in less than four hours avoiding extreme pain and saving life without neurological side effects, on the other side the University has been obtaining yearly R&D grants for new BTI’s scientist’s research collaborations, and annual royalties for the global antivenin sells. Silanes expanded their manufacturing plant facilities in only five years, investing the revenues of the antivenin sells. Besides of that, the Bioclon R&D Institute is in a permanent growing process performing continuous antivenin research in conjunction with their technological partners.
As shown in Figure I the intellectual property strategy has been perfectly aligned with the business strategy, sales expectations will be continuously increasing for the next decades improving local economy and saving lives in many countries all over the world. Those are the distinctive issues of the innovation project performed by world class technology allied organizations team. UNAM’s BTI-Silanes & Bioclon have developed the antivenin product and process technology as their core competences for the 21st century. (Nadler & Tuchman, 1999).
Undoubtedly even though the project time length was very long, the money investment required was very high, and it was required high quality knowledge capital which is scarce and difficult to find, the economic and social benefits of the innovation project presented overcome all the efforts and therefore projects like these must be pursued in Latin America specially those originated in public universities.

Tags: , , ,